TI
RYTM icon

Trexquant Investment’s Rhythm Pharmaceuticals RYTM Stock Holding History

Trexquant Investment’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-37,161
Closed -$3.75M – 1883
2025
Q3 		$3.75M Buy
37,161
+30,078
+425% +$2.79M 0.04% 655
2025
Q2 		$448K Sell
7,083
-31,641
-82% -$1.94M 0.01% 1289
2025
Q1 		$2.05M Buy
38,724
+30,926
+397% +$1.72M 0.02% 863
2024
Q4 		$437K Buy
+7,798
New +$431K 0.01% 1318
2023
Q4 		– Sell
-24,514
Closed -$562K – 1734
2023
Q3 		$562K Buy
+24,514
New +$549K 0.01% 969
2021
Q2 		– Sell
-11,535
Closed -$245K – 1451
2021
Q1 		$245K Buy
+11,535
New +$335K 0.02% 864
2018
Q3 		– Sell
-12,950
Closed -$405K – 1163
2018
Q2 		$405K Buy
+12,950
New +$354K 0.03% 605

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Trexquant Investment's RYTM Position: Q4 2025 in Review

Trexquant Investment sold out of Rhythm Pharmaceuticals (RYTM) in Q4 2025, closing a stake of 37,161 shares — an estimated $3.75M sold.

Trexquant Investment first reported a position in RYTM in Q2 2018 and held it in 7 quarters. The position peaked at $3.75M in Q3 2025. 279 funds tracked by Wall St. Rank hold RYTM as of Q4 2025.

  • Trexquant Investment reported no remaining Rhythm Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Trexquant Investment sold 37,161 Rhythm Pharmaceuticals shares in Q4 2025, an estimated $3.75M.
  • Trexquant Investment first reported a position in Rhythm Pharmaceuticals in Q2 2018 and held it in 7 quarters.
  • Trexquant Investment's Rhythm Pharmaceuticals position peaked at $3.75M in Q3 2025.
  • 279 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q4 2025.

Based on Trexquant Investment's 13F filing for Q4 2025, filed 17 Feb 2026.